Frontierby eninvs

Language: EN · RU

← Region

ELI LILLY & Co USD

At a glance: strengths & risks
✓Revenue growing (+45%)✓Profit growing (+95%)✓Margins improving (32%→43%)✓Cheaper than own history (EV/EBITDA 33.1 vs avg 60.3)

Sector: Health care

US_LLY

Price chart

1 185.87 USDDay 1.97%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
1 185.87 USD · 1.97%
Market cap
1061.1 bn USD

Growth

Δ revenue y/y
55.5%
Δ EBITDA y/y
138.8%

Multiples

P/E (LTM)
42.0x
3y avg: 84.0x
P/B (FY)
40.0x
P/E (ann.)
35.9x
EV/EBITDA (LTM)
33.1x
3y avg: 60.3x
EV/EBITDA (ann.)
29.4x

Cash return

Dividend yield
0.5%
FCF yield (LTM)
0.7%

Value creation

fundamental value/yr, % of market cap
Value created / year
+38.6%
↓ details

Liquidity

Daily turnover (US listing)
2.3 bln USD

Shares: yahoo_fundamentals_timeseries/LLY

Financial results

Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB USDOperating profitB USDD&AB USDEBITDAB USDNet profitB USDOperating CFB USDCapex + M&AB USDAssetsB USDEquityB USDROE (annualized)Net debtB USDSource
2026-03-31Q1 2026 (3M)OK19.8
y/y 55.5%
8.8
y/y 156.1%
0.5
y/y 9.9%
9.4
y/y 138.8%
7.4
y/y 168.1%
5.3-3.4116.6
y/y 30.4%
31.2
y/y 97.9%
102.5%38.1Link
2025-12-31Q4 2025 (3M)OK19.3
y/y 42.6%
8.3
y/y 64.1%
0.6
y/y 20.7%
8.9
y/y 60.3%
6.6
y/y 50.5%
3.2-3.2112.5
y/y 42.9%
26.5
y/y 85.9%
82.0%36.6Link
2025-09-30Q3 2025 (3M)OK17.6
y/y 53.9%
7.2
y/y 355.3%
0.5
y/y 0.7%
7.7
y/y 274.8%
5.6
y/y 475.3%
8.8-2.1114.9
y/y 52.0%
23.8
y/y 67.1%
35.4%32.6Link
2025-06-30Q2 2025 (3M)OK15.6
y/y 37.6%
6.8
y/y 92.7%
0.5
y/y 15.4%
7.3
y/y 84.5%
5.7
y/y 90.8%
3.1-1.7100.9
y/y 40.4%
18.3
y/y 34.7%
133.0%36.4Link
2025-03-31Q1 2025 (3M)OK12.7
y/y 45.2%
3.5
y/y 36.3%
0.5
y/y 15.6%
3.9
y/y 33.4%
2.8
y/y 23.0%
1.7-1.589.4
y/y 39.8%
15.8
y/y 23.0%
73.5%35.3Link
2024-12-31Q4 2024 (3M)OK13.5
y/y 44.7%
5.0
y/y 100.9%
0.5
y/y 25.2%
5.5
y/y 90.8%
4.4
y/y 101.4%
2.5-2.478.7
y/y 23.0%
14.3
y/y 32.5%
74.3%31.4Link
2024-09-30Q3 2024 (3M)OK11.4
y/y 20.4%
1.6
y/y 271.8%
0.5
y/y 13.6%
2.1
y/y 145.2%
1.0
y/y —
3.7-1.475.6
y/y 30.5%
14.2
y/y 26.9%
9.3%27.6Link
2024-06-30Q2 2024 (3M)OK11.3
y/y 36.0%
3.5
y/y 68.4%
0.4
y/y 13.1%
3.9
y/y 60.1%
3.0
y/y 68.3%
1.5-1.271.9
y/y 31.1%
13.6
y/y 22.6%
90.0%25.5Link
2024-03-31Q1 2024 (3M)OK8.8
y/y 26.0%
2.5
y/y 65.8%
0.4
y/y 10.6%
2.9
y/y 55.2%
2.2
y/y 66.8%
1.2-1.063.9
y/y 20.3%
12.8
y/y 14.5%
76.1%23.6Link
2023-12-31Q4 2023 (3M)OK9.4
y/y —
2.5
y/y —
0.4
y/y —
2.9
y/y —
2.2
y/y —
-0.3-2.164.0
y/y —
10.8
y/y —
47.7%23.4Link
2023-09-30Q3 2023 (3M)OK9.5
y/y —
0.4
y/y —
0.4
y/y —
0.8
y/y —
-0.1
y/y —
2.2-1.057.9
y/y —
11.2
y/y —
-0.7%17.7Link
2023-06-30Q2 2023 (3M)OK8.3
y/y —
2.1
y/y —
0.4
y/y —
2.5
y/y —
1.8
y/y —
0.6-0.754.8
y/y —
11.1
y/y —
63.4%16.0Link
2023-03-31Q1 2023 (3M)OK7.0
y/y —
1.5
y/y —
0.4
y/y —
1.9
y/y —
1.3
y/y —
1.7-0.753.2
y/y —
11.2
y/y —
—15.2Link

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

05 00010 00015 00020 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Year-over-year change

0%100%200%300%2023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Cash flow

FCF ($ mln)

-4 000-2 00002 0004 0006 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Net debt / cash ($ mln)

010 00020 00030 00040 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Fundamental value creation

Value the company creates per year, as a % of market cap

Value created per year: +38.6%

How this was calculated
1. EBITDA growth (latest quarter YoY, annualised)
[EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2026-03-31 vs 2025-03-31)
= (9 359 − 3 919) × 3.54
19 279
2. Current EV/EBITDA (LTM)
(Market cap + Net debt) ÷ EBITDA (LTM)
= (1 061 116 + 38 088) ÷ 33 168
30.0x — capped at 30x
3. Target multiple
(Current EV/EBITDA + 12) ÷ 2
= (30.0 + 12) ÷ 2
21.0x
4. Cash flow (balance method, LTM)
Net-debt reduction + dividends + buybacks − equity issuance
= -2 793 + 4 240 + 3 756 − 0
5 204
5. Value created per year
(EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap
= (19 279 × 21.0 + 5 204) ÷ 1 061 116
+38.6%

Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.

Revenue growth & acceleration

Growth accelerating ▲
Last-year revenue growth +45% vs +32% the year before — a +12.7 pp move. 3-year CAGR +32%.
revenue growth by year: 2023 +20% · 2024 +32% · 2025 +45%
The growth-acceleration signal behind the GARP+acceleration strategy — it favours companies whose revenue growth is speeding up and flags those slowing down (the second derivative of growth).

EV/EBITDA — daily history

Current 32.6x · 3-year average 73.2x

EV/EBITDA3-year 75th pct

Dividends

Paid (completed)

DatePer shareDetailsStatusSource
2026-05-151.73 USDEx-dividend: 1.73 USD per sharePaidYahoo Finance (ex-div)
2026-02-131.73 USDEx-dividend: 1.73 USD per sharePaidYahoo Finance (ex-div)
2025-11-141.5 USDEx-dividend: 1.5 USD per sharePaidYahoo Finance (ex-div)
2025-08-151.5 USDEx-dividend: 1.5 USD per sharePaidYahoo Finance (ex-div)
2025-05-161.5 USDEx-dividend: 1.5 USD per sharePaidYahoo Finance (ex-div)
2025-02-141.5 USDEx-dividend: 1.5 USD per sharePaidYahoo Finance (ex-div)
2024-11-151.3 USDEx-dividend: 1.3 USD per sharePaidYahoo Finance (ex-div)
2024-08-151.3 USDEx-dividend: 1.3 USD per sharePaidYahoo Finance (ex-div)
2024-05-151.3 USDEx-dividend: 1.3 USD per sharePaidYahoo Finance (ex-div)
2024-02-141.3 USDEx-dividend: 1.3 USD per sharePaidYahoo Finance (ex-div)
2023-11-141.13 USDEx-dividend: 1.13 USD per sharePaidYahoo Finance (ex-div)
2023-08-141.13 USDEx-dividend: 1.13 USD per sharePaidYahoo Finance (ex-div)
2023-05-121.13 USDEx-dividend: 1.13 USD per sharePaidYahoo Finance (ex-div)
2023-02-141.13 USDEx-dividend: 1.13 USD per sharePaidYahoo Finance (ex-div)
2022-11-140.98 USDEx-dividend: 0.98 USD per sharePaidYahoo Finance (ex-div)
2022-08-120.98 USDEx-dividend: 0.98 USD per sharePaidYahoo Finance (ex-div)
2022-05-130.98 USDEx-dividend: 0.98 USD per sharePaidYahoo Finance (ex-div)
2022-02-140.98 USDEx-dividend: 0.98 USD per sharePaidYahoo Finance (ex-div)
2021-11-120.85 USDEx-dividend: 0.85 USD per sharePaidYahoo Finance (ex-div)
2021-08-120.85 USDEx-dividend: 0.85 USD per sharePaidYahoo Finance (ex-div)

KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).

Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)

Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of ELI LILLY & Co — from primary filings.

Pharmaceutical innovation—diabetes, obesity, oncology, immunology, and neuroscience therapies.

Frequently asked questions

What is ELI LILLY & Co's P/E ratio?
ELI LILLY & Co trades at a P/E of 42.0x (price to trailing 12-month earnings).
What is ELI LILLY & Co's EV/EBITDA?
ELI LILLY & Co trades at 33.1x EV/EBITDA.
What is ELI LILLY & Co's P/B ratio?
ELI LILLY & Co trades at a P/B of 40.0x.
What is ELI LILLY & Co's dividend yield?
ELI LILLY & Co's trailing 12-month dividend yield is 0.5%.
What is ELI LILLY & Co's return on equity (ROE)?
ELI LILLY & Co's ROE is 102.5%.
What is ELI LILLY & Co's market capitalization?
ELI LILLY & Co's market cap is 1061.1 bn USD.